{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:33:50Z","timestamp":1790804030632,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"HARMONICSS","award":["731944"],"award-info":[{"award-number":["731944"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.autrev.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T12:34:23Z","timestamp":1545050063000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Lymphomagenesis in Sj\u00f6gren's syndrome: Predictive biomarkers towards precision medicine"],"prefix":"10.1016","volume":"18","author":[{"given":"Andreas V.","family":"Goules","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.08.007_bb0005","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2018.08.007_bb0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.autrev.2016.03.004","article-title":"Primary Sjgren's syndrome: clinical phenotypes, outcome and the development of biomarkers","volume":"15","author":"Goules","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.007_bb0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sjgren syndrome","volume":"14","author":"Papageorgiou","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.08.007_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00296-014-3051-x","article-title":"Identification of lymphoma predictors in patients with primary Sjogren's syndrome: a systematic literature review and meta-analysis","volume":"35","author":"Nishishinya","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.08.007_bb0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sjogren's syndrome: autoimmune epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.08.007_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","article-title":"Insight into pathogenesis of Sjogren's syndrome: dissection on autoimmune infiltrates and epithelial cells","volume":"182","author":"Goules","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0050","doi-asserted-by":"crossref","first-page":"E579","DOI":"10.1503\/cmaj.122037","article-title":"Sjogren syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.autrev.2018.08.007_bb0055","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3899\/jrheum.130256","article-title":"Minor salivary gland inflammatory lesions in Sjogren syndrome: do they evolve?","volume":"40","author":"Kapsogeorgou","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0060","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/art.1780290907","article-title":"Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjogren's syndrome","volume":"29","author":"Tzioufas","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005792-200007000-00005","article-title":"Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome","volume":"79","author":"Goules","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2018.08.007_bb0070","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.38100","article-title":"Clinically significant renal involvement in primary Sjogren's syndrome: clinical presentation and outcome","volume":"65","author":"Goules","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e328363eaa5","article-title":"New advances in the classification, pathogenesis and treatment of Sjogren's syndrome","volume":"25","author":"Mavragani","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/03009749609065654","article-title":"Probability of the development of non-Hodgkin's lymphoma in primary Sjogren's syndrome","volume":"25","author":"Hernandez","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.1780390219","article-title":"Long-term followup of patients with Sjogren's syndrome","volume":"39","author":"Kruize","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0090","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sjogren's syndrome","volume":"45","author":"Lazarus","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.08.007_bb0095","first-page":"1296","article-title":"Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976\u20131992","volume":"26","author":"Martens","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mpo.2950200403","article-title":"Lymphoma in Sjogren's syndrome","volume":"20","author":"Pavlidis","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sjogren's syndrome","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0110","first-page":"2376","article-title":"Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome","volume":"24","author":"Valesini","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/03009749509095178","article-title":"Primary Sjogren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS","volume":"24","author":"Zufferey","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982\u20132003","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.08.007_bb0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zeron","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.08.007_bb0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A longitudinal cohort study of Finnish patients with primary Sjogren's syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.08.007_bb0140","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2018.08.007_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116189","article-title":"Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients","volume":"10","author":"Papageorgiou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.08.007_bb0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0160","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.08.007_bb0165","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V89.9.3335","article-title":"Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas","volume":"89","author":"Bahler","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.08.007_bb0170","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1182\/blood.V86.9.3528.bloodjournal8693528","article-title":"Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma","volume":"86","author":"Qin","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.08.007_bb0175","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/art.21936","article-title":"Identification of transitional type II B cells in the salivary glands of patients with Sjogren's syndrome","volume":"54","author":"Daridon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0185","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.0803588","article-title":"Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells","volume":"182","author":"Le Pottier","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0190","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.08.007_bb0195","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","article-title":"Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome","volume":"44","author":"Amft","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0200","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.180.7.5130","article-title":"CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization","volume":"180","author":"Barone","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0205","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sjogren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0215","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0220","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3899\/jrheum.131527","article-title":"Evaluation of germinal center-like structures and B cell clonality in patients with primary Sjogren syndrome with and without lymphoma","volume":"41","author":"Johnsen","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0225","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity","volume":"201","author":"Bende","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.08.007_bb0230","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood.V95.12.3878.012k26_3878_3884","article-title":"Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features","volume":"95","author":"Miklos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.08.007_bb0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/path.1711630413","article-title":"Detection of Epstein-Barr virus antigens and DNA in major and minor salivary glands using immunocytochemistry and polymerase chain reaction: possible relationship with Sjogren's syndrome","volume":"163","author":"Deacon","year":"1991","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.136.2.477","article-title":"Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome","volume":"136","author":"Fox","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.1999.00778.x","article-title":"Ro\/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjogren's syndrome","volume":"115","author":"Halse","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2559.1993.tb00487.x","article-title":"Plasma cell populations in labial salivary glands from patients with and without Sjogren's syndrome","volume":"23","author":"Matthews","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2018.08.007_bb0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0714.1990.tb00810.x","article-title":"Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjogren's syndrome","volume":"19","author":"Speight","year":"1990","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2018.08.007_bb0260","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0265","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2018.08.007_bb0270","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1074-7613(03)00323-6","article-title":"Activation of autoreactive B cells by CpG dsDNA","volume":"19","author":"Viglianti","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2018.08.007_bb0275","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fimmu.2013.00509","article-title":"Non-Canonical NF-kappaB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures","volume":"4","author":"Gardam","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0280","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.08.007_bb0285","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0290","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/10428190903013334","article-title":"B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity","volume":"50","author":"Ferrer","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.autrev.2018.08.007_bb0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-005-4091-5","article-title":"Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome","volume":"25","author":"Jonsson","year":"2005","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0300","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.08.007_bb0305","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/0008-5472.CAN-08-4915","article-title":"Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma","volume":"69","author":"Novak","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2018.08.007_bb0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","article-title":"B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome","volume":"51","author":"Nezos","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.08.007_bb0315","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20100857","article-title":"A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling","volume":"207","author":"Hildebrand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.08.007_bb0320","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/art.39231","article-title":"A BAFF receptor His159Tyr mutation in Sjogren's syndrome-related lymphoproliferation","volume":"67","author":"Papageorgiou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0325","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1079-2104(96)80331-3","article-title":"Lymphoma in Sjogren's syndrome. From histopathology to molecular pathology","volume":"81","author":"Jordan","year":"1996","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.autrev.2018.08.007_bb0330","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","article-title":"BAFF: a local and systemic target in autoimmune diseases","volume":"158","author":"Moisini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0335","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors","volume":"46","author":"Brito-Zeron","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.08.007_bb0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.08.007_bb0345","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","article-title":"Clinical features distinguishing lymphoma development in primary Sjogren's Syndrome--a retrospective cohort study","volume":"43","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0350","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2018.08.007_bb0355","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","article-title":"The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren's syndrome","volume":"73","author":"Risselada","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.08.007_bb0360","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203314554251","article-title":"A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjogren's syndrome","volume":"24","author":"Carubbi","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.08.007_bb0365","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/art.23073","volume":"56","author":"Manoussakis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0370","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjogren's syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.08.007_bb0375","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/art.38129","article-title":"Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjogren's syndrome","volume":"65","author":"Tobon","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.08.007_bb0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.08.007_bb0385","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/annrheumdis-2017-212639","article-title":"Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjogren's syndrome","volume":"77","author":"Kapsogeorgou","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:20Z","timestamp":1761599660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1568997218302866"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.08.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphomagenesis in Sj\u00f6gren's syndrome: Predictive biomarkers towards precision medicine","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}